The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Grant

A Phase 1b/2a Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy

Sponsored by Longboard Pharmaceuticals, Inc.

Active
$543.6K Funding
3 People
External

Related Topics

People